Af­ter all the love and mon­ey, an­a­lysts spec­u­late that J&J may swoop in with a buy­out of­fer for Gen­mab

Gen­mab Chief Ex­ec­u­tive Jan van de Winkel doesn’t un­der­state his af­fec­tion for J&J. When the two com­pa­nies tied the knot over Darza­lex, the CEO de­scribed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.